Clinical Trial Update: Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the combination of narrow-band UVB phototherapy with etanercept for psoriasis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Amgen | Conditions: Psoriasis | Phase 4 | Status: COMPLETED